⌕
Bausch Health Companies · BHC · NYSE
Tenet 50 · Mixed
Compare
$8.35+1.21%At closeTenet 50 · Mixed
$8.35+0.10 (+1.21%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE · USD

Bausch Health Companies (BHC) Stock

Bausch Health Companies (BHC) closed at $8.35 on Nov 13, 2026; its Tenet Score is 50 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

26 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$8.35
Nov 13, 2026
Market cap
$3.1B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
4.33 – 9.04
low → high
Tenet Score
50/100
Mixed · 409 Healthcare peers

Industry: Drugs · see every company filed here →

Bausch Health Companies Inc scores 50/100. Mixed. Strongest on value, financial health is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
50/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
87
Quality
54
Health
16
Growth
45

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueBQualityCHealthFGrowthDMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
—
Not meaningful: shareholders' equity is zero or negative.
P/S
0.3×
price to fiscal 2025 sales
ROE
—
Not meaningful: shareholders' equity is zero or negative.
Operating margin
17.7%
fiscal 2025, before interest and tax
Net margin
−7.5%
of revenue kept
Current ratio
1.56
current assets to liabilities
Net debt / EBITDA
7.3×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Bausch Health Companies Inc

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatol…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 10 US ETFs · top wrappers by weightSee all ETFs holding BHC →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Bausch Health Companies in?

Bausch Health Companies is in the Healthcare sector and the Drugs industry.

What is Bausch Health Companies' Tenet Score?

Bausch Health Companies' Tenet Score is 50 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.